Brief: Thor Medical H2 EBITDA Loss Is NOK 28.9 Mln
26/02/2025 06:14
Feb 26 (Reuters) - Thor Medical ASA TRMED.OL: H2 REVENUE NOK 0.0 MILLION H2 EBITDA LOSS NOK 28.9 MILLION Source text: ID:nObiBjBB8a Further company coverage: TRMED.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln